Cardiac disease in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20241445Keywords:
Mortality, 2D ECHO, Congenital heart diseaseAbstract
Cardiac disease is an important cause of maternal morbidity and mortality. It can invariably affect fetus with variable intensity depending upon nature of cardiac disease in mother. Cardiac disease can affect women antenatally, in labor and even in post-partum period. It is a case series of 12 cases who presented to labor room in a particular unit at SSG hospital, Baroda over a period of 1 year starting from 1st May 2022 to 30th April 2023. Mean age at presentation was 24.8. 3 women were having valvular heart disease while 4 were having peri-partum cardiomyopathy (PPCM), 4 were having atrial septal defect (ASD), 1 was having ventricular septal defect (VSD). Associated medical comorbidities and obstetrical factors were evaluated. 2D ECHO findings of all cases were recorded. Risk assessment must be done for the mother and fetus to minimize the effect of cardiac disease in pregnancy. Joint consultation with cardiologist should be done in already known case of cardiac disease.
References
Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016;68(4):396-410.
Farhan HA, Yaseen IF. Heart disease in pregnancy-clinical pattern and prevalence: initial data from the first cardio-maternal unit in Iraq. BMC Res Notes. 2019;12(1):491.
Shrestha P, Kuikel S, Bajracharya S, Ghimire A, Shrestha R, Mishra A, et al. Pregnancy with heart disease in South Asia: A systematic review and meta-analysis of prevalence and outcome. Ann Med Surg (Lond). 2022;80:104293.
El Ghali EH, Meziyane J, Aouragh S, Taheri H, Saadi H, Mimouni A. Cardiac disease and pregnancy: a case series of 19 patients. Int J Reprod Contracept Obstet Gynecol 2022;11:1574-7.
Poli PA, Orang'o EO, Mwangi A, Barasa FA. Factors Related to Maternal Adverse Outcomes in Pregnant Women with Cardiac Disease in Low-resource Settings. Eur Cardiol. 2020;15:e68.
Lumsden R, Barasa F, Park LP, Ochieng CB, Alera JM, Millar HC, et al. High Burden of Cardiac Disease in Pregnancy at a National Referral Hospital in Western Kenya. Glob Heart. 2020;15(1):10
Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy Outcomes in Women with Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018;71(21):2419-30.
Shyamsundar B, Vinayraju D, Garag S. A clinical study on maternal heart diseases complicating pregnancy at tertiary care hospital. N Indian J Obgyn. 2021;7(2):219-23.
Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124-32.
Bužinskienė D, Domža G, Dulko J, Olšauskaitė M, Drąsutienė G, Liekienė D. Valvular heart disease during pregnancy: a clinical case and a literature review. Acta Med Litu. 2018;25(3):140-50.
Reimold SC Rutherford JD. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52-9.
James AH. Pregnancy and thrombotic risk. Crit Care Med. 2010;38(2):S57-63.
Galambosi PJ, Kaaja RJ, Stefanovic V, Ulander V-M. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):154-9.
James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation. 2006;113(12):1564-71.
Lindley KJ, Madden T, Cahill AG, Ludbrook PA, Billadello JJ. Contraceptive Use and Unintended Pregnancy in Women with Congenital Heart Disease. Obstet Gynecol. 2015;126(2):363-9.
